Brent Johnson Biography and Net Worth

VP of Iradimed


Brent Johnson was the executive vice president of worldwide sales and marketing for iRadimed, a medical device developer. 

iRadimed is an innovator of magnetic resonance imaging (MRI) compatible medical devices. Their signature product is a non-magnetic intravenous (IV) infusion pump system designed to be safe for use during MRI procedures. iRadimed was the first to create an infusion delivery system that curtails many of the issues during MRI procedures. 

Johnson joined iRadimed in 2012. With his guidance, iRadimed reached compound annual sales growth of 26 percent by expanding the international distributor network, growing its U.S. sales force and entering new markets. He retired from the company in 2020. 

Before iRadimed, Johnson was the vice president of sales and marketing at Xhale, Inc., GE Walker, Inc., and Invivo Corp. between 1996 and 2012. He began his career at Datascope in 1985 culminating as the regional sales manager.

Johnson holds a bachelor of science in finance from San Diego State University.

What is Brent Johnson's net worth?

The estimated net worth of Brent Johnson is at least $363,725.40 as of April 6th, 2020. Mr. Johnson owns 6,940 shares of Iradimed stock worth more than $363,725 as of May 1st. This net worth estimate does not reflect any other investments that Mr. Johnson may own. Learn More about Brent Johnson's net worth.

How do I contact Brent Johnson?

The corporate mailing address for Mr. Johnson and other Iradimed executives is 1025 Willa Springs Dr., Winter Springs FL, 32708. Iradimed can also be reached via phone at (407) 677-8022 and via email at investorrelations@iradimed.com. Learn More on Brent Johnson's contact information.

Has Brent Johnson been buying or selling shares of Iradimed?

Brent Johnson has not been actively trading shares of Iradimed within the last three months. Most recently, Brent Johnson sold 4,000 shares of the business's stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $20.01, for a transaction totalling $80,040.00. Following the completion of the sale, the vice president now directly owns 6,940 shares of the company's stock, valued at $138,869.40. Learn More on Brent Johnson's trading history.

Who are Iradimed's active insiders?

Iradimed's insider roster includes Monty Allen (Director), John Glenn (CFO), James Hawkins (Director), Brent Johnson (VP), Christopher Scott (CFO), Roger Susi (CEO), and Anthony Vuoto (Director). Learn More on Iradimed's active insiders.

Are insiders buying or selling shares of Iradimed?

During the last year, insiders at the medical equipment provider sold shares 1 times. They sold a total of 2,500 shares worth more than $135,450.00. The most recent insider tranaction occured on December, 2nd when CFO John Glenn sold 2,500 shares worth more than $135,450.00. Insiders at Iradimed own 37.1% of the company. Learn More about insider trades at Iradimed.

Information on this page was last updated on 12/2/2024.

Brent Johnson Insider Trading History at Iradimed

Brent Johnson Buying and Selling Activity at Iradimed

This chart shows Brent Johnson's buying and selling at Iradimed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2$0Total Insider BuyingTotal Insider Selling

Iradimed Company Overview

Iradimed logo
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
Read More

Today's Range

Now: $52.41
Low: $51.96
High: $53.47

50 Day Range

MA: $52.40
Low: $48.67
High: $55.70

2 Week Range

Now: $52.41
Low: $40.86
High: $63.29

Volume

37,757 shs

Average Volume

44,302 shs

Market Capitalization

$666.39 million

P/E Ratio

34.94

Dividend Yield

1.28%

Beta

0.82